WSFS FINANCIAL CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that WSFS FINANCIAL CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $963.95M | Feb 28, 2023 |
| FY2022 | Dec 31, 2021 | $641.85M | Feb 28, 2023 |
| FY2022 | Dec 31, 2020 | $715.43M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $709.20M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $455.51M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $379.37M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $321.64M | Feb 28, 2019 |
| FY2017 | Dec 31, 2015 | $272.83M | Mar 1, 2018 |
| FY2016 | Dec 31, 2014 | $238.62M | Mar 1, 2017 |
| FY2015 | Dec 31, 2013 | $227.07M | Feb 29, 2016 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $287.35M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $263.67M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $269.16M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $222.38M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $271.44M | Feb 29, 2024 |
| FY2020 | Dec 31, 2020 | $59.81M | Mar 1, 2021 |
| FY2020 | Sep 30, 2020 | $51.15M | Mar 1, 2021 |
| FY2020 | Jun 30, 2020 | ($7.11M) | Mar 1, 2021 |
| FY2020 | Mar 31, 2020 | $10.93M | Mar 1, 2021 |
| FY2020 | Dec 31, 2019 | $45.70M | Mar 1, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $220.00M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $219.90M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $237.00M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $480.85M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $125.65M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $15.14M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $89.87M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $135.57M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $130.17M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $80.18M | Feb 28, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.39M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $14.26M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $6.41M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $8.81M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $6.58M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $7.16M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $14.20M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $5.50M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $7.73M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $9.87M | Feb 28, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $21.31B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $20.81B | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $20.59B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $19.91B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $15.78B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $14.33B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $12.26B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $7.25B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $7.00B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $6.77B | Mar 1, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $18.59B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $18.23B | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $18.12B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $17.71B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $13.84B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $12.54B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $10.41B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $6.43B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $6.28B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $6.08B | Mar 1, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.74B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $2.59B | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $2.48B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $2.21B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $1.94B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $1.79B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $1.85B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $820.92M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $724.35M | Feb 28, 2019 |
| FY2018 | Dec 31, 2016 | $687.34M | Feb 28, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $885.22M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $885.90M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $885.90M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $883.64M | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | $472.83M | Feb 29, 2024 |
| FY2022 | Dec 31, 2020 | $472.83M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $472.83M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $166.01M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $166.01M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $167.54M | Feb 28, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.12B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $1.87B | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $1.64B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $1.41B | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $1.22B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $977.41M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $917.38M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $791.03M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $669.56M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $627.08M | Mar 1, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.70B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $1.15B | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $1.09B | Feb 28, 2025 |
| FY2023 | Dec 31, 2022 | $837.26M | Feb 29, 2024 |
| FY2022 | Dec 31, 2021 | $1.53B | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $1.65B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $571.75M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $620.76M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $723.87M | Feb 28, 2019 |
| FY2018 | Dec 31, 2016 | $821.92M | Feb 28, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2013 | $21.99M | Mar 16, 2015 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5 | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 4 | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | 4 | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | 5 | Feb 29, 2024 |
| FY2020 | Dec 31, 2020 | 1 | Mar 1, 2021 |
| FY2020 | Sep 30, 2020 | 1 | Mar 1, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Mar 1, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Mar 1, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Mar 1, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5 | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 4 | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | 4 | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Feb 28, 2025 |
| FY2023 | Dec 31, 2021 | 5 | Feb 29, 2024 |
| FY2020 | Dec 31, 2020 | 1 | Mar 1, 2021 |
| FY2020 | Sep 30, 2020 | 1 | Mar 1, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Mar 1, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Mar 1, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Mar 1, 2021 |